Detalles de la búsqueda
1.
Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.
J Viral Hepat
; 2022 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35583922
2.
Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program.
Med J Aust
; 215(7): 332-333, 2021 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34346057
3.
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.
Hepatol Commun
; 6(3): 496-512, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729957
4.
The changing characteristics of patients with chronic hepatitis C prescribed direct acting antiviral medicines in general practice since listing of the medicines on the Australian Pharmaceutical Benefits Scheme.
JGH Open
; 5(7): 813-819, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34263077
5.
Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort.
Int J Drug Policy
; 96: 103422, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34426040
6.
Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
Addiction
; 111(2): 311-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26451534
Resultados
1 -
6
de 6
1
Próxima >
>>